Methylxanthines for the treatment of apnea associated with bronchiolitis and anesthesia.
McNamara
David G
DG
Department of Respiratory Medicine, Starship Children's Hospital, Auckland, New Zealand. d.mcnamara@auckland.ac.nz
Nixon
Gillian M
GM
Anderson
Brian J
BJ
D000768:Anesthesia, General / Q000009:adverse effects*; D001049:Apnea / Q000188:drug therapy* / Q000209:etiology; D001988:Bronchiolitis / Q000150:complications / Q000188:drug therapy*; D002110:Caffeine / Q000494:pharmacology / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D007235:Infant, Premature, Diseases / Q000188:drug therapy; D019141:Respiratory System Agents / Q000494:pharmacology / Q000627:therapeutic use*; D013806:Theophylline / Q000494:pharmacology / Q000627:therapeutic use*
D019141:Respiratory System Agents; D002110:Caffeine; D013806:Theophylline